Skip to main content

Multimodal imaging in parkinsonisms: from the molecular synaptic pruning to the whole-brain connectomics

Project description

Imaging technology to improve diagnostic of Parkinsonism

Parkinsonism is the second most prevalent neurodegenerative disorder after Parkinson’s disease (PD), and 20 % of patients are diagnosed with atypical parkinsonisms (AP). AP tends to be therapy-resistant and presents a faster degeneration rate than PD. The EU-funded SYNPARK project is an interdisciplinary action that will investigate the value of the different imaging markers' modalities in various parkinsonism forms. Improving diagnostic accuracy is important now, when disease-modifying therapies are becoming available for PD. The research involves a multidisciplinary approach of the in vivo synaptic molecular brain assessment using positron emission tomography (PET), the whole-brain connectomics organisation using magnetic resonance imaging and the clinical validation of a new generation PET tracer in AP/PD.

Coordinator

UNIVERSITAT DE BARCELONA
Net EU contribution
€ 232 497,60
Address
Gran Via De Les Corts Catalanes 585
08007 Barcelona
Spain

See on map

Region
Este Cataluña Barcelona
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00

Partners (1)

Partner

Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.

CENTRE FOR ADDICTION AND MENTAL HEALTH
Canada
Net EU contribution
€ 0,00
Non-EU contribution
€ 152 031,36